gallocatechol has been researched along with Diabetic Glomerulosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrei, S; Chandramohan, V; Dramane, P; Eklu-Gadegbeku, K; Kpemissi, M; Lawson-Evi, P; Melila, M; Metowogo, K; Potârniche, AV; Puneeth, TA; S, VK; Sevastre, B; Suhas, DS; Taulescu, M; Veerapur, VP; Vlase, L | 1 |
1 other study(ies) available for gallocatechol and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Nephroprotective effect of Combretum micranthum G. Don in nicotinamide-streptozotocin induced diabetic nephropathy in rats: In-vivo and in-silico experiments.
Topics: Animals; Biomarkers; Blood Glucose; Catechin; Combretum; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hypoglycemic Agents; Kidney; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Niacinamide; Oxidative Stress; Plant Extracts; PPAR alpha; PPAR gamma; Rats, Wistar; Signal Transduction; Streptozocin | 2020 |